Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Cinven Said to Buy Medpace From CCMP for $900 Million

Feb. 24 (Bloomberg) -- Cinven Ltd., a Europe-focused private-equity firm, is nearing an agreement to buy Medpace Inc., a provider of clinical developmental services for the pharmaceutical and biotechnology industries, from buyout owner CCMP Capital, according to two people familiar with the talks.

Cinven may pay about $900 million for the Cincinnati-based company, said the people, who asked not to be identified because negotiations are confidential. An agreement could be announced as early as today, they said. Representatives for Cinven and CCMP declined to comment.

Medpace, which focuses on small to mid-sized companies, is benefiting from increased research and development spending by pharmaceutical and biotechnology firms for clinical trials. Cinven mainly invests in six sectors, including health care, and past investments include U.K. specialty pharmaceuticals firm Amdipharm Mercury, or AMCo, and French protein-testing company Sebia, according to its website.

CCMP, which was spun off from JPMorgan Chase & Co., bought Medpace in 2011, according to its website. Medpace, which was established in 1992, has operations in more than 45 countries and more than 1,500 employees.

Reuters previously reported that Cinven agreed to buy Medpace.

To contact the reporters on this story: Kiel Porter in London at kporter17@bloomberg.net; Aaron Kirchfeld in London at akirchfeld@bloomberg.net

To contact the editors responsible for this story: Aaron Kirchfeld at akirchfeld@bloomberg.net; Edward Evans at eevans3@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.